Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1997-11-5
|
pubmed:abstractText |
1/1 atrial tachycardia or "quinidine" flutter under class I antiarrhythmic drugs is a serious complication of these agents which, unfortunately, cannot be anticipated. The aim of this study was to review the cases of 11 patients who had suffered this complication of class I antiarrhythmic therapy to see if it could have been prevented. All drugs of this class were included. The 11 subjects were aged 57 to 78: 7 had no apparent underlying cardiac disease and the others had valvular (n = 1), hypertensive (n = 1) and ischaemic (n = 2) heart disease. They were treated for episodes of paroxysmal atrial fibrillation or tachycardia. In the absence of treatment, 7 patients had a short PR interval on the ECG (PR between 0.11 and 0.14 s). In the other 4, the PR interval was normal (0.16 to 0.20 s), but the P wave was widened with appearances of left atrial hypertrophy or an intra-atrial conduction defect. High amplification ECG performed in 3 patients showed continuity of atrial and ventricular depolarisation. Atrial stimulation showed excellent nodal conduction with a Wenckebach point of 200/min. The authors conclude that a short PR interval is predisposing factor to 1/1 atrial tachycardia with class I antiarrhythmics. High amplification ECG which allows identification of the end of the P wave with respect to the QRS complex could help identify subjects at risk when the P wave is widened and that, consequently, the PR interval appears to be normal.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Arrhythmia Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Disopyramide,
http://linkedlifedata.com/resource/pubmed/chemical/Flecainide,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Propafenone,
http://linkedlifedata.com/resource/pubmed/chemical/Quinidine,
http://linkedlifedata.com/resource/pubmed/chemical/cifenline
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0003-9683
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
961-6
|
pubmed:dateRevised |
2009-2-13
|
pubmed:meshHeading |
pubmed-meshheading:9339257-Aged,
pubmed-meshheading:9339257-Anti-Arrhythmia Agents,
pubmed-meshheading:9339257-Atrial Flutter,
pubmed-meshheading:9339257-Disopyramide,
pubmed-meshheading:9339257-Electrocardiography,
pubmed-meshheading:9339257-Female,
pubmed-meshheading:9339257-Flecainide,
pubmed-meshheading:9339257-Heart Conduction System,
pubmed-meshheading:9339257-Humans,
pubmed-meshheading:9339257-Imidazoles,
pubmed-meshheading:9339257-Male,
pubmed-meshheading:9339257-Middle Aged,
pubmed-meshheading:9339257-Predictive Value of Tests,
pubmed-meshheading:9339257-Propafenone,
pubmed-meshheading:9339257-Quinidine,
pubmed-meshheading:9339257-Risk Factors
|
pubmed:year |
1997
|
pubmed:articleTitle |
[Can 1/1 atrial flutter be foreseen by class I anti-arrhythmics?].
|
pubmed:affiliation |
Service de cardiologie A, CHU de Brabois, Vandoeuvre.
|
pubmed:publicationType |
Journal Article,
English Abstract
|